3-(4-chlorophenyl)-5-hydroxy-3-methyl-6-(pyrimidin-4-ylamino)-2,5-dihydroimidazo[1,5-a]pyridin-1-one
C18H16ClN5O2 — CID 142483379
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-chlorophenyl)-5-hydroxy-3-methyl-6-(pyrimidin-4-ylamino)-2,5-dihydroimidazo[1,5-a]pyridin-1-one
3-(4-chlorophenyl)-5-hydroxy-3-methyl-6-(pyrimidin-4-ylamino)-2,5-dihydroimidazo[1,5-a]pyridin-1-one (PubChem CID 142483379) has the molecular formula C18H16ClN5O2 and a molecular weight of 369.81 g/mol. Its IUPAC name is 3-(4-chlorophenyl)-5-hydroxy-3-methyl-6-(pyrimidin-4-ylamino)-2,5-dihydroimidazo[1,5-a]pyridin-1-one.
Molecular Properties
| Compound Name | 3-(4-chlorophenyl)-5-hydroxy-3-methyl-6-(pyrimidin-4-ylamino)-2,5-dihydroimidazo[1,5-a]pyridin-1-one |
|---|---|
| PubChem CID | 142483379 |
| Molecular Formula | C18H16ClN5O2 |
| Molecular Weight | 369.81 g/mol |
| Exact Mass | 369.10 |
| IUPAC Name | 3-(4-chlorophenyl)-5-hydroxy-3-methyl-6-(pyrimidin-4-ylamino)-2,5-dihydroimidazo[1,5-a]pyridin-1-one |
| SMILES | CC1(c2ccc(Cl)cc2)NC(=O)C2=CC=C(Nc3ccncn3)C(O)N21 |
| InChI | InChI=1S/C18H16ClN5O2/c1-18(11-2-4-12(19)5-3-11)23-16(25)14-7-6-13(17(26)24(14)18)22-15-8-9-20-10-21-15/h2-10,17,26H,1H3,(H,23,25)(H,20,21,22) |
| InChIKey | SCZOBGWXVVYOLF-UHFFFAOYSA-N |
| XLogP | 1.95 |
| TPSA | 90.38 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 369.81 |
| LogP ≤ 5 | 1.95 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142483379 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.